Initially, we evaluated the growth of the unique genetically unmodified ER+ BC cell models (LetR1 and LetR3), which mimic resistance to the AI letrozole due to local estrogen synthesis through aromatization of testosterone (aromatase-mediated growth condition)35. This evidence concerns the gene CYP19A1 and breast cancer.